Literature DB >> 26040498

Lipiodol injections for optimization of target volume delineation in a patient with a second tumor of the oropharynx: A case report.

Marlen Haderlein1, Ricarda Merten, Andrea Stojanovic, Stefan Speer, Claudia Scherl, Rainer Fietkau, Oliver J Ott.   

Abstract

BACKGROUND: Lipiodol injections were administered in the head and neck area to improve gross tumor volume (GTV) definition for small-volume re-irradiation of a 63-year-old previously irradiated patient with a second tumor of the oropharynx in the posterior wall with longitudinal ligament infiltration (cT4cN0cM0).
METHODS: The patient had dialysis-depending renal failure. On diagnostic computed tomography (CT), which was performed with intravenous contrast agent, the tumor in the oropharynx was not detectable. Because of dialysis-depending renal failure comorbidity, no contrast agent was applied in the planning CT and in the diagnostic magnetic resonance imaging (MRI) study. In each cross-sectional imaging study performed, the GTV, especially in craniocaudal extensions, was not safely delineable. Therefore, craniocaudal tumor margins were pharyngoscopically marked with Lipiodol injections, an iodine-containing contrast agent.
RESULTS: In a second planning CT, the GTV could be defined with the help of the Lipiodol marks and small-volume re-irradiation was performed. No Lipiodol-associated side effects occurred in the patient.
CONCLUSION: In the present case, the use of Lipiodol injections at the tumor margins facilitated the definition of the GTV.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26040498     DOI: 10.1007/s00066-015-0856-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  18 in total

1.  Intensity-modulated radiotherapy for laryngeal and hypopharyngeal cancer: minimization of late dysphagia without jeopardizing tumor control.

Authors:  Anouchka Modesto; Anne Laprie; Laure Vieillevigne; Pierre Graff; Jérôme Sarini; Sébastien Vergez; Jean-Pierre Delord; Jean-Claude Farenc; Emmanuelle Vigarios; Thomas Filleron; Michel Rives
Journal:  Strahlenther Onkol       Date:  2014-11-01       Impact factor: 3.621

Review 2.  Quality-improvement guidelines for hepatic transarterial chemoembolization.

Authors:  Antonio Basile; Gianpaolo Carrafiello; Anna Maria Ierardi; Dimitrios Tsetis; Elias Brountzos
Journal:  Cardiovasc Intervent Radiol       Date:  2012-05-31       Impact factor: 2.740

Review 3.  The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach.

Authors:  Jon Cacicedo; Arturo Navarro; Filippo Alongi; Alfonso Gómez de Iturriaga; Olga Del Hoyo; Elsira Boveda; Francisco Casquero; Jose Fernando Perez; Pedro Bilbao
Journal:  Cancer Treat Rev       Date:  2013-08-08       Impact factor: 12.111

4.  Long-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancer.

Authors:  Allen M Chen; Yao Yu; Megan E Daly; D Gregory Farwell; Stanley H Benedict; James A Purdy
Journal:  Head Neck       Date:  2014-03-25       Impact factor: 3.147

5.  Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.

Authors:  M Lambrecht; D Nevens; S Nuyts
Journal:  Strahlenther Onkol       Date:  2013-01-16       Impact factor: 3.621

Review 6.  Planting the seeds of success: CT-guided gold seed fiducial marker placement to guide robotic radiosurgery.

Authors:  Aashish Patel; Bhavraj Khalsa; Bryce Lord; Kumar Sandrasegaran; Chandana Lall
Journal:  J Med Imaging Radiat Oncol       Date:  2012-09-21       Impact factor: 1.735

7.  The German registry for nephrogenic systemic fibrosis: findings from 23 patients.

Authors:  S Becker; S Walter; O Witzke; B Wilde; U Hillen; D Napieralski; A Kreuter; P Altmeyer; G Schieren; A Daul; L-C Rump; A Kribben
Journal:  Clin Nephrol       Date:  2010-06       Impact factor: 0.975

8.  Behavior of lipiodol markers during image guided radiotherapy of bladder cancer.

Authors:  Xiangfei Chai; Marcel van Herk; Jeroen B van de Kamer; Peter Remeijer; Axel Bex; Anja Betgen; Theo M De Reijke; Maarten C C M Hulshof; Floris J Pos; Arjan Bel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-04       Impact factor: 7.038

9.  Evaluation of tumor shape variability in head-and-neck cancer patients over the course of radiation therapy using implanted gold markers.

Authors:  Olga Hamming-Vrieze; Simon Robert van Kranen; Suzanne van Beek; Wilma Heemsbergen; Marcel van Herk; Michiel Wilhelmus Maria van den Brekel; Jan-Jakob Sonke; Coenraad Robert Nico Rasch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-05       Impact factor: 7.038

10.  Second primary malignancies in head and neck cancer patients: high prevalence of curable-stage disease.

Authors:  H A Wolff; C R M Wolff; C F Hess; K Jung; S Sennhenn-Kirchner; M Hinterthaner; A Müller-Dornieden; W Körber; K Marten-Engelke; R Roedel; H Christiansen; C Engelke
Journal:  Strahlenther Onkol       Date:  2013-07-12       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.